Secukinumab improves active psoriatic arthritis symptoms and inhibits radiographic progression: primary results from the randomised, double-blind, phase III FUTURE 5 study

Author(s):: Mease, P.; Heijde, D. van der; Landewe, R.; Mpofu, S.; Rahman, P.; Tahir, H.; Singhal, A.; Boettcher, E.; Navarra, S.; Meiser, K.; Readie, A.; Pricop, L.; Abrams, K.

Published: 2018
Publication type: Article / Letter to editor

dmards (biologic)cytokinestreatmentpsoriatic arthritis

Date issued: 2018-06-30
Language: English
Is part of: Annals of the Rheumatic Diseases (2018), Vol. 77, no. 6, p. 890-897
hdl: 1887/76088
doi: 10.1136/annrheumdis-2017-212687